MIA:
- WHO ATC First Level (Anatomical main group) ID: B BLOOD AND BLOOD FORMING ORGANS
- WHO ATC Second Level (Therapeutic subgroup) ID: B06 OTHER HEMATOLOGICAL AGENTS
- WHO ATC Third Level (Pharmacological subgroup) ID: B06A OTHER HEMATOLOGICAL AGENTS
- WHO ATC Fourth Level (Chemical subgroup) ID: B06AC Drugs used in hereditary angioedema
- WHO ATC Fifth Level (Chemical substance) ID: B06AC02 Icatibant
- Chemical Name: Icatibant
- Chemical Smi: OC[C@@H](C(=O)N1Cc2ccccc2CC1C(=O)N1[C@H]2CCCC[C@H]2CC1C(=O)N[C@H](C(=O)O)CCCN=C(N)N)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)C1C[C@H](CN1C(=O)C1CCCN1C(=O)C(NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)O
- WHO ICD Mapped Level : T78.3 T78.3 Name: Angioneurotic oedema
- WHO ICD Fourth Level ID: T78.3 T78.3 Name: Angioneurotic oedema
- WHO ICD Third Level ID: T78 T78 Name: Adverse effects, not elsewhere classified
- WHO ICD Second Level ID: T66-T78 T66-T78 Name: Other and unspecified effects of external causes
- WHO ICD First Level ID: XIX XIX Name: Injury, poisoning and certain other consequences of external causes
|
|